{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-24-000010","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2024-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.152563+00:00","generated_at":"2026-06-05T02:31:50.764826+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"OrthoPediatrics FY 2023 revenue $148.7M (+22% YoY); guides FY 2024 rev $197-200M","bullets":["FY 2023 net loss $21.0M ($0.92/share) vs net income $1.3M ($0.06) in 2022; adjusted EBITDA rose to $5.0M from $0.2M.","Q4 2023 revenue $37.6M (+21% YoY); gross margin 71.0% vs 68.5%; U.S. revenue +24%, international +13%.","FY 2024 revenue guidance $197-200M (+32-34%); adjusted EBITDA guidance $8-9M.","Acquired Boston Orthotics & Prosthetics with $80M debt financing; post-close cash ~$60M."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-24-000010","json":"https://secwatch.observer/filing/0001425450-24-000010.json","markdown":"https://secwatch.observer/filing/0001425450-24-000010.md","text":"https://secwatch.observer/filing/0001425450-24-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000010/0001425450-24-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000010/kids-20240306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T02:31:50.764826+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"632cee43f2534847bb41bb6e041f49d557840d5b","claim":"ORTHOPEDIATRICS CORP reported the full year ended December 31, 2023 results: revenue $148.7 million. Guidance reaffirmed.","evidence_excerpt":"Record full year 2023 revenue of $148.7 million increased 22% compared to prior year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000010/0001425450-24-000010-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2023"},{"label":"Revenue","value":"$148.7 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"7068ea115969596dc67efa4f52050b4a94775788","claim":"ORTHOPEDIATRICS CORP reported the fourth quarter ended December 31, 2023 results: revenue $37.6 million. Guidance reaffirmed.","evidence_excerpt":"Generated total revenue of $37.6 million for fourth quarter 2023, up 21% from $31.0 million in fourth quarter 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000010/0001425450-24-000010-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$37.6 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"78191998574200676ac8a264eaf792e9cece31d9","claim":"ORTHOPEDIATRICS CORP reported full year 2024 results: revenue $197.0 million to $200.0 million. Guidance reaffirmed.","evidence_excerpt":"Reiterated full year 2024 revenue guidance to be in a range of $197.0 million to $200.0 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545024000010/0001425450-24-000010-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2024"},{"label":"Revenue","value":"$197.0 million to $200.0 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}